| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | DE4041185A1 Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren Use of hirudin and its muteins for combination treatment of tumors |
| 06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
| 06/24/1992 | EP0491053A1 Water-soluble bis-dioxopiperazine derivatives with antitumoral properties |
| 06/24/1992 | EP0491018A1 Use of taurolidine and/or taurultam for the treatment of tumours |
| 06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/23/1992 | US5124083 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/22/1992 | WO1992011290A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | WO1992011024A1 Use of hirudine and its muteines and their peg derivatives for the combined treatment of tumours |
| 06/22/1992 | CA2098926A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | CA2098707A1 Use of hirudin, its muteins and the peg derivatives thereof for the combination treatment of tumors |
| 06/22/1992 | CA2058247A1 Tert-butyloxcarbonyl-1-tyrosyl-peptidoglycan monomer and 1251-labelled derivative thereof, their preparation and use |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/19/1992 | WO1992011034A1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 06/19/1992 | CA2098198A1 Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| 06/19/1992 | CA2057842A1 Human monoclonal antibody |
| 06/18/1992 | WO1992011035A1 Improved treatment method for cancer |
| 06/17/1992 | EP0490878A1 New 3'-(4-Morpholinyl)- anthracycline derivatives |
| 06/17/1992 | EP0490816A2 Fluoro-compounds |
| 06/17/1992 | EP0490648A1 Pharmaceutical agents |
| 06/17/1992 | EP0490598A1 Antitumoral and antiviral compound |
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0490380A2 Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent |
| 06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
| 06/17/1992 | EP0489846A1 Antisense oligonucleotides to c-abl proto-oncogene |
| 06/17/1992 | CN1061974A 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 06/16/1992 | US5122537 Tyrosine kinase inhibitors |
| 06/16/1992 | US5122535 Method of solubilizing melatonine in water |
| 06/16/1992 | US5122368 Anthracycline conjugates having a novel linker and methods for their production |
| 06/16/1992 | CA1303613C Substituted indoloquinoxalines |
| 06/16/1992 | CA1303524C Drug-monoclonal antibody conjugates |
| 06/15/1992 | WO1992010207A1 Oral administration of alpha interferon to treat lung malignancies |
| 06/15/1992 | CA2098393A1 Oral administration of alpha interferon to treat lung malignancies |
| 06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
| 06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
| 06/11/1992 | WO1992009610A1 Drug delivery porphyrin compositions and methods |
| 06/11/1992 | WO1992009607A1 Ecteinascidins 736 and 722 |
| 06/11/1992 | WO1992009589A1 Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/11/1992 | WO1992009563A1 Improved matrix metalloprotease inhibitors |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | DE4039559A1 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln Functionalized vinylazoles, processes for their preparation, pharmaceutical compositions containing them and their use for vinylazoles preparation of medicaments |
| 06/11/1992 | CA2096225A1 Matrix metalloprotease inhibitors |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489579A1 Peptidyl derivatives |
| 06/10/1992 | EP0489577A1 Peptidyl derivatives |
| 06/10/1992 | EP0489178A1 Antitumor agent |
| 06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 06/09/1992 | US5120842 Immunosuppresive activity, antitumor agents, fungicides |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120759 Tetrahydronaphthalene derivatives for improving short-term memory |
| 06/09/1992 | US5120740 Targeting antitumor drugs to kidneys |
| 06/09/1992 | US5120727 Rapamycin dimers |
| 06/09/1992 | US5120725 Antibody inhibitors |
| 06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | CA2056970A1 Antitumoral and antiviral compound |
| 06/05/1992 | WO1992010202A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 06/05/1992 | CA2056810A1 Extract from mixture of phellodendron and seed of croton, method for the same and drug containing the same |
| 06/04/1992 | WO1992009565A1 Peptidyl derivatives |
| 06/04/1992 | WO1992009564A1 Peptidyl derivatives |
| 06/04/1992 | DE4038128A1 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them |
| 06/04/1992 | CA2073513A1 Peptidyl derivatives |
| 06/04/1992 | CA2073510A1 Peptidyl derivatives |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488513A2 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. |
| 06/03/1992 | EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 06/03/1992 | EP0488383A1 2-beta,19-ethylene bridged steroids as aromatase inhibitors |
| 06/03/1992 | EP0487930A1 Process for preparing benzo[C]phenanthridinium derivatives, and novel compounds prepared by said process |
| 06/03/1992 | EP0487525A1 Tuftsin analogs |
| 06/03/1992 | EP0452391A4 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 06/02/1992 | US5118709 Arylhydrazones and pharmaceutical compositions containing the same |
| 06/02/1992 | US5118677 For treating transplant rejection, host vs. draft disease, autoimmune diseases and inflammations; antibody inhibitors |
| 06/02/1992 | US5118674 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them |
| 06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 06/02/1992 | US5118500 Side effect reduction when administering a xanthine derivative |
| 06/02/1992 | CA1302416C Platinum triamine antitumor agents |
| 06/02/1992 | CA1302405C Ergoline derivatives |
| 06/02/1992 | CA1302270C Carcinostatic agent |
| 05/31/1992 | CA2056693A1 Compounds |
| 05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008802A1 Bispecific antibodies, method of production, and uses thereof |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/28/1992 | WO1992009618A1 8-ENE-19, 11β-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 05/28/1992 | CA2097079A1 8-ene-19, 11.bet.beta.-bridged steroids, their preparation and pharma ceutical formulations containing them |
| 05/27/1992 | EP0487502A2 Pharmaceutically active aryl-substituted amine derivatives |
| 05/27/1992 | EP0487207A1 Benzolactam analogs as antagonists of CCK |
| 05/27/1992 | EP0487097A1 Pyrazoloacridone derivatives |
| 05/27/1992 | EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent |